Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Harvard Bioscience Inc

+ Add to Watchlist

HBIO:US

5.2100 USD 0.0300 0.57%

As of 20:10:00 ET on 01/30/2015.

Snapshot for Harvard Bioscience Inc (HBIO)

Open: 5.2500 Day's Range: 5.1400 - 5.2500 Volume: 40,804
Previous Close: 5.2400 52wk Range: 3.6800 - 5.9300 1-Yr Rtn: +17.87%

Stock Chart for HBIO

No chart data available.
  • HBIO:US 5.2100
  • 1D
  • 1M
  • 1Y
5.2400
Interactive HBIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HBIO

Current P/E Ratio (ttm) 32.8605
Estimated P/E(12/2014) 25.4146
Relative P/E vs. SPX 1.8705
Earnings Per Share (USD) (ttm) 0.1585
Est. EPS (USD) (12/2014) 0.2050
Est. PEG Ratio 1.2707
Market Cap (M USD) 168.91
Shares Outstanding (M) 32.42
30 Day Average Volume 118,911
Price/Book (mrq) 1.7430
Price/Sale (ttm) 1.5609
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HBIO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HBIO

Harvard Bioscience, Inc. develops, manufactures, and markets tools used in drug discovery research and pharmaceutical and biotechnology companies, universities, and government laboratories. The Company's tools include proteomics products that allow researchers to purify and analyze proteins and ADMET screening products that test drug candidates.

Jeffrey A Duchemin "Jeff"President/CEO/SecretaryRobert E Gagnon "Rob"CFO/Treasurer
Yoav SibonyVP:Global SalesYong SunVP:Strategic Marketing
More Company Profile & Key Executives for HBIO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil